GSK3a-IN-38

CAS No. 1062138-03-7

GSK3a-IN-38( —— )

Catalog No. M37037 CAS No. 1062138-03-7

GSK3a-IN-38 is a novel small molecule compound that has inhibitory effects on GSK-3a.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 34 In Stock
10MG 52 In Stock
25MG 93 In Stock
50MG 146 In Stock
100MG 228 In Stock
200MG 340 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    GSK3a-IN-38
  • Note
    Research use only, not for human use.
  • Brief Description
    GSK3a-IN-38 is a novel small molecule compound that has inhibitory effects on GSK-3a.
  • Description
    GSK3a-IN-38 is a novel small molecule compound that has inhibitory effects on GSK-3a.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    PI3K/Akt/mTOR signaling
  • Target
    GSK-3
  • Recptor
    GSK-3
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1062138-03-7
  • Formula Weight
    308.38
  • Molecular Formula
    C18H20N4O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C1C2=C(NC=3NN=C(C3C2C=4C=CN=CC4)C)CC(C)(C)C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • BRD1172

    BRD1172 is a highly selective, potent, reversible, ATP-competitive GSK3 inhibitor with IC50 of 3 nM/10 nM for GSK3α/GSK3β, respectively.

  • GSK3β-IN-1a

    GSK3β-IN-1a is a relatively selective and potent GSK-3β inhibitor with IC50 of 64 nM.

  • GSK-3 Inhibitor XIII

    GSK-3 Inhibitor XIII, an ATP-competitive GSK-3 inhibitor (Ki: 24 nM), can be used to study diabetes and obesity.